ELEVANCE HEALTH, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ELEVANCE HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $100.00M, a 8.70% increase year-over-year.
- ELEVANCE HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $58.00M, a 11.54% increase year-over-year.
- ELEVANCE HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $92.00M, a 15.60% decline year-over-year.
- ELEVANCE HEALTH, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $92.00M, a 39.47% decline year-over-year.
- ELEVANCE HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $323.00M, a 5.90% increase from fiscal 2024.
- ELEVANCE HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $305.00M, a 10.82% decline from fiscal 2023.
- ELEVANCE HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $342.00M, a 2.84% decline from fiscal 2022.
- ELEVANCE HEALTH, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $352.00M, a 0.85% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $100.00M 10-Q · filed 2026-07-15 | |
| 2026-03-31 | $58.00M 10-Q · filed 2026-07-15 | |
| 2025-12-31 | $323.00M 10-K · filed 2026-02-06 | |
| 2025-09-30 | $92.00M 10-Q · filed 2025-10-21 | |
| 2025-06-30 | $92.00M 10-Q · filed 2026-07-15 | |
| 2025-03-31 | $52.00M 10-Q · filed 2026-07-15 | |
| 2024-12-31 | $305.00M 10-K · filed 2026-02-06 | |
| 2024-09-30 | $109.00M 10-Q · filed 2025-10-21 | |
| 2024-06-30 | $152.00M 10-Q · filed 2025-10-21 | |
| 2024-03-31 | $59.00M 10-Q · filed 2025-10-21 | |
| 2023-12-31 | $342.00M 10-K · filed 2026-02-06 | |
| 2023-09-30 | $109.00M 10-Q · filed 2024-10-17 | |
| 2023-06-30 | $116.00M 10-Q · filed 2024-10-17 | |
| 2023-03-31 | $6.00M 10-Q · filed 2024-10-17 | |
| 2022-12-31 | $352.00M 10-K · filed 2025-02-20 | |
| 2022-09-30 | $103.00M 10-Q · filed 2023-10-18 | |
| 2022-06-30 | $111.00M 10-Q · filed 2023-10-18 | |
| 2022-03-31 | $39.00M 10-Q · filed 2023-10-18 | |
| 2021-12-31 | $355.00M 10-K · filed 2024-02-21 | |
| 2021-09-30 | $75.00M 10-Q · filed 2022-10-19 | |
| 2021-06-30 | $119.00M 10-Q · filed 2022-10-19 | |
| 2021-03-31 | $62.00M 10-Q · filed 2022-10-19 | |
| 2020-12-31 | $330.00M 10-Q · filed 2023-10-18 | |
| 2020-09-30 | $98.00M 10-Q · filed 2021-10-20 | |
| 2020-06-30 | $113.00M 10-Q · filed 2021-10-20 | |
| 2020-03-31 | $3.00M 10-Q · filed 2021-10-20 | |
| 2019-12-31 | $396.00M 10-K · filed 2022-02-16 | |
| 2019-09-30 | $120.00M 10-Q · filed 2020-10-28 | $406.00M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | $91.00M 10-Q · filed 2020-10-28 | $381.00M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $69.00M 10-Q · filed 2020-10-28 | $359.00M derived: sum of 4 quarters · filed 2021-02-18 |
| 2018-12-31 | $126.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $318.00M 10-K · filed 2021-02-18 |
| 2018-09-30 | $95.00M 10-Q · filed 2019-10-23 | $278.00M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $69.00M 10-Q · filed 2019-10-23 | $251.00M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $28.00M 10-Q · filed 2019-10-23 | $270.10M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $86.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $342.00M 10-K · filed 2020-02-19 |
| 2017-09-30 | $68.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $319.50M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-06-30 | $88.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $315.40M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-03-31 | $99.90M 10-Q · filed 2018-04-25 | $288.30M derived: sum of 4 quarters · filed 2019-02-20 |
| 2016-12-31 | $63.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $249.00M 10-K · filed 2019-02-20 |
| 2016-09-30 | $63.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $245.90M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-06-30 | $61.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $235.90M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-03-31 | $60.60M 10-Q · filed 2017-04-26 | $262.20M derived: sum of 4 quarters · filed 2018-02-21 |
| 2015-12-31 | $60.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $308.20M 10-K · filed 2018-02-21 |
| 2015-09-30 | $53.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $322.40M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | $87.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $406.80M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $106.60M 10-Q · filed 2016-04-27 | $408.60M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $74.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $444.00M 10-K · filed 2017-02-22 |
| 2014-09-30 | $138.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $556.30M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $89.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $681.80M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $142.00M 10-Q · filed 2015-04-29 | $766.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $186.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $672.40M 10-K · filed 2016-02-19 |
| 2013-09-30 | $263.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | |
| 2013-06-30 | $173.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | |
| 2013-03-31 | $48.40M 10-Q · filed 2014-04-30 | |
| 2012-09-30 | $53.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $201.10M derived: sum of 4 quarters · filed 2013-10-23 |
| 2012-06-30 | $83.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-24 | $199.40M derived: sum of 4 quarters · filed 2013-07-24 |
| 2012-03-31 | $40.10M 10-Q · filed 2013-04-24 | $332.40M derived: sum of 4 quarters · filed 2013-04-24 |
| 2011-12-31 | $24.20M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $339.80M 10-K · filed 2012-02-22 |
| 2011-09-30 | $52.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $380.70M derived: sum of 4 quarters · filed 2012-11-07 |
| 2011-06-30 | $216.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $392.70M derived: sum of 4 quarters · filed 2012-07-25 |
| 2011-03-31 | $47.50M 10-Q · filed 2012-04-25 | $244.70M derived: sum of 4 quarters · filed 2012-04-25 |
| 2010-12-31 | $65.10M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $266.00M 10-K · filed 2012-02-22 |
| 2010-09-30 | $64.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-26 | $286.40M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | $68.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | $304.00M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | $68.80M 10-Q · filed 2011-04-27 | $313.30M derived: sum of 4 quarters · filed 2012-02-22 |
| 2009-12-31 | $85.50M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $271.40M 10-K · filed 2012-02-22 |
| 2009-09-30 | $81.70M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-03 | $223.90M derived: sum of 4 quarters · filed 2011-02-17 |
| 2009-06-30 | $77.30M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-03 | $200.90M derived: sum of 4 quarters · filed 2011-02-17 |
| 2009-03-31 | $26.90M 10-Q · filed 2010-04-28 | |
| 2008-12-31 | $38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $281.00M 10-K · filed 2011-02-17 |
| 2008-09-30 | $58.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-28 | |
| 2007-12-31 | $1.12B 10-K · filed 2010-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |